A team of researchers have been awarded more than £450,000 by Cancer Research UK to investigate a new way of preventing the division and growth of tumour cells. The team at the University of Bath, led by Mike Threadgill of the department of pharmacy and pharmacology, will be targeting a family of enzymes that appear to be involved in controlling cell growth. By finding a way of preventing these enzymes from working, it may be possible to halt the progression of cancer.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.
